[Metabolic and immunologic effects of cyclosporine administration in new insulin-dependent diabetics].
Assan
R
R
Debray-Sachs
M
M
Laborie
C
C
Chatenoud
L
L
Feutren
G
G
Quiniou-Debrie
M C
MC
Thomas
G
G
Bach
J F
JF
D000917:Antibody Formation; D001323:Autoantibodies / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D007111:Immunity, Cellular; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000276:immunology
D001323:Autoantibodies; D001786:Blood Glucose; D007328:Insulin; D016572:Cyclosporine
Effets métaboliques et immunologiques de l'administration de cyclosporine chez les diabétiques insulino-dépendants récents.